Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833

NCT00001383 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00001383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Completed
Start date
March 31, 1994
Completion date
January 31, 2001
Enrollment
52
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cancer, carcinoma, renal cell, lymphoma, ovarian cancer